Validation period: 2/9/2023, 12:01:56 PM - 2/10/2023, 12:01:56 PM
BMJ Journals logo
Home/Browse by collection/Guidelines and Consensus Statements
Email alerts

Guidelines and Consensus Statements

Section Edited by Robert L. Ferris, MD, PhD

Showing results 11 - 20 of 39

Sorted by most recent

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of urothelial cancer
Matthew D Galsky, Arjun V Balar, Peter C Black, Matthew T Campbell, Gail S Dykstra, Petros Grivas, Shilpa Gupta, Christoper J Hoimes, Lidia P Lopez, Joshua J Meeks, Elizabeth R Plimack, Jonathan E Rosenberg, Neal Shore, Gary D Steinberg, Ashish M Kamat

15 July 2021

Immune-related adverse events associated with immune checkpoint inhibitors: a call to action for collecting and sharing clinical trial and real-world data
Kerry L Reynolds, Shaily Arora, Ravikumar Komandur Elayavilli, William C Louv, Teilo H Schaller, Aakanksha Khandelwal, Mace Rothenberg, Sean Khozin, Amanda C Guidon, Michael Dougan, Leyre Zubiri, Laura Petrillo, Meghan E Sise, Alexandra-Chloe Villani, Douglas B JohnsonSee the full list of authors

2 July 2021

SITC Society Logo
  • Latest content
  • Browse by collection
  • Archive
  • Top cited articles
Website Terms & ConditionsPrivacy & CookiesContact BMJCookie settingsOnline ISSN: 2051-1426Copyright © 2023 BMJ Publishing Group Ltd and Society for Immunotherapy of Cancer. All rights reserved.